Pages that link to "Q34451574"

The following pages link to Impact of constitutional polymorphisms in VCAM1 and CD44 on CD34+ cell collection yield after administration of granulocyte colony-stimulating factor to healthy donors. (Q34451574):

Displaying 18 items.

• Transmissible cytotoxicity of multiple myeloma cells by cord blood-derived NK cells is mediated by vesicle trafficking (Q27331909) (← links)
• A novel association between relaxin receptor polymorphism and hematopoietic stem cell yield after mobilization. (Q33860021) (← links)
• New insights in the mobilization of hematopoietic stem cells in lymphoma and multiple myeloma patients. (Q34114055) (← links)
• Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis (Q34749174) (← links)
• G-CSF in Healthy Allogeneic Stem Cell Donors (Q37180718) (← links)
• Optimized granulocyte colony-stimulating factor prophylaxis in adult cancer patients: from biological principles to clinical guidelines. (Q37996443) (← links)
• Prediction of hematopoietic stem cell yield after mobilization with granulocyte-colony-stimulating factor in healthy unrelated donors (Q40727125) (← links)
• A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT. (Q46031355) (← links)
• Management of mobilization failure in 2017. (Q49887745) (← links)
• Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G-CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5-year follow-up study (Q50506365) (← links)
• Single nucleotide polymorphisms of the DGKB and VCAM1 genes are associated with granulocyte colony stimulating factor-mediated peripheral blood stem cell mobilization. (Q52837251) (← links)
• A nationwide survey of the use of plerixafor in patients with lymphoid malignancies who mobilize poorly demonstrates the predominant use of the "on-demand" scheme of administration at French autologous hematopoietic stem cell transplant programs. (Q53508311) (← links)
• Autologous Transplantation for Older Adults with AML (Q58716610) (← links)
• A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT (Q63253927) (← links)
• Mobilized peripheral blood: an updated perspective (Q89558892) (← links)
• Analysis of a large single institution cohort of related donors fails to detect a relation between SDF1/CXCR4 or VCAM/VLA4 genetic polymorphisms and the level of hematopoietic progenitor cell mobilization in response to G-CSF (Q90065178) (← links)
• Impact of CD44 gene single nucleotide polymorphism (rs 13347) in mobilization of autologous HSCT (Q97068394) (← links)
• CD markers polymorphisms as prognostic biomarkers in hematological malignancies (Q98386581) (← links)